Medical corporate offering CGM to non-diabetic patients under new ‘health optimisation’ serviceÂ
A high-profile telehealth corporate is offering men a preventive health program involving a suite of tests such as testosterone, HbA1C and cholesterol, with results sent to the patient’s usual GP.
The move has prompted concerns from MDOs about pathology being ordered outside of a patient’s regular GP practice.
Eucalyptus, whose doctors are known for prescribing compounded semaglutide for weight loss, and counts Dr Nick Coatsworth and Dr Malcolm Parmenter as clinical governance advisers, opened its new venture last month.
Called Compound, patients pay $995 a month for the 12-week program, where they are offered non-subsidised continuous glucose monitoring (CGM) — even if they do not have diabetes — plus gait analysis, a dual-energy X-ray absorptiometry scan, VO2 max testing, a diet plan and an exercise program, as well as various supplements.
